Stoquity Living researchResearch LedgerSlicesMethodologyFor institutionsAbout
Stoquity Research Ledger

Henry Schein (HSIC)

NASDAQ: HSIC · Health Care Distributors · Melville, NY

Our rating: Positive

Call changed from Neutral to Positive at $88.24, moderate conviction, November 4, 2026.

Breaks if: The Positive call loses its support if trailing-twelve-month free cash flow falls below $550M — compressing the FCF yield to under 5.6% at today's price — in any quarterly report through the end of 2027, or if year-over-year revenue growth prints below 2% for two consecutive quarters. Either outcome would signal that the cash-generative franchise the view rests on is weakening structurally, not simply reflecting an earnings-timing mismatch.

Key figures

Market value$9.2B
Revenue, last 12 months$13.7B
Net income, last 12 months$421M
Free cash flow, last 12 months$559M
Price to earnings21.9×
Free cash flow yield6.1%
Dividend yield0.0%
Operating margin5.2%
Return on equity12.9%
Beta to the S&P 5000.55
Volatility, annualized27.4%

Reported quarters

Quarter endingRevenueYear on yearEarnings per shareFree cash flow
September 26, 2026$3.5B4.0%$1.06$131M
June 27, 2026$3.5B6.7%$0.82$212M
March 28, 2026$3.4B6.3%$0.92−$122M
December 27, 2025$3.4B7.7%$0.85$338M
September 27, 2025$3.3B5.2%$0.84$141M
June 28, 2025$3.2B3.3%$0.70$88M
March 29, 2025$3.2B−0.1%$0.88$6M
December 28, 2024$3.2B5.8%$0.75$168M

Three-model forecasts for the next quarter

Written November 21, 2026, before the report. Each settles from the SEC filing.

10 ledger entries and 53 corporate events on record. Share price as of November 20, 2026. Research and education only. Not investment advice. Stoquity does not manage money or know your circumstances. Ratings, forecasts and lists are produced by software and AI models and can be wrong. Performance figures are hypothetical, measured on paper against a benchmark, and say nothing certain about the future.